Cargando…

Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant

Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker for the diagnosis of acute allograft injury within the first 1 to 2 y after lung transplant, but its utility for diagnosing chronic lung allograft dysfunction (CLAD) has not yet been studied. Understanding baseline dd-cfDNA kinetics beyond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trindade, Anil J., Chapin, Kaitlyn C., Mullican, Amy, Gray, Jennifer N., Hoy, Haley, Demarest, Caitlin T., Lambright, Eric S., McPherson, Katie A., Norfolk, Stephanie G., Robbins, Ivan M., Bacchetta, Matthew, Erasmus, David B., Shaver, Ciara M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Lung Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671749/ https://www.ncbi.nlm.nih.gov/pubmed/36406896 http://dx.doi.org/10.1097/TXD.0000000000001411

Ejemplares similares

Relative Change in Donor-Derived Cell-free DNA is Superior to Absolute Values for Diagnosis of Acute Lung Allograft Dysfunction
por: Trindade, Anil J., et al.
Publicado: (2023)

Surviving White-out: How to Manage Severe Noninfectious Acute Lung Allograft Dysfunction of Unknown Etiology
por: Trindade, Anil J., et al.
Publicado: (2022)

An Initial Analysis of the Baseline Levels of Dd-cfDNA After Pancreas Transplantation: A Prospective Study From High-volume Centers in the United States
por: Yoo, Ashley, et al.
Publicado: (2023)

Pulmonary Allograft Versus Host Disease
por: Dai, David W., et al.
Publicado: (2017)

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection
por: Le Pavec, Jérôme, et al.
Publicado: (2021)

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021)

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022)

Epidemiologic Analysis of Delta Variant SARS-CoV-2 in a Cohort of Lung Transplant Recipients
por: Shaver, C.M., et al.
Publicado: (2022)

Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
por: Li, Jenny, et al.
Publicado: (2023)

Effect of β-Nicotinamide Adenine Dinucleotide on Acute Allograft Rejection After Rat Lung Transplantation
por: Ehrsam, Jonas P., et al.
Publicado: (2023)

Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung Transplantation
por: Saito, Masao, et al.
Publicado: (2018)

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022)

Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience
por: Benvenuto, Luke, et al.
Publicado: (2022)

A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation
por: Sommer, Wiebke, et al.
Publicado: (2021)

Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells
por: Ward, C, et al.
Publicado: (2009)

One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience
por: Laothamatas, Kemarut, et al.
Publicado: (2022)

Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
por: Guo, Qiao-mei, et al.
Publicado: (2019)

High levels of dd‐cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury
por: Stites, Erik, et al.
Publicado: (2020)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
por: Yeh, Jason, et al.
Publicado: (2021)

Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias
por: Fierro-Pineda, Juan C., et al.
Publicado: (2023)

Efflux capacity and aldehyde dehydrogenase both contribute to CD8(+) T-cell resistance to posttransplant cyclophosphamide
por: Patterson, Michael T., et al.
Publicado: (2022)

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
por: Maurer, Katie, et al.
Publicado: (2023)

Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells
por: Rolandsson, Sara, et al.
Publicado: (2014)

A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation
por: Corris, Paul A, et al.
Publicado: (2015)

Low Levels of Exhaled Surfactant Protein A Associated With BOS After Lung Transplantation
por: Ericson, Petrea A., et al.
Publicado: (2016)

Prevalence of gastrointestinal dysmotility and complications detected by abdominal plain films after lung transplantation: a single-centre cohort study
por: Heinrich, Henriette, et al.
Publicado: (2016)

Intravascular donor monocytes play a central role in lung transplant ischaemia-reperfusion injury
por: Tatham, Kate Colette, et al.
Publicado: (2018)

Long-term outcomes of patients with pulmonary arteriovenous malformations considered for lung transplantation, compared with similarly hypoxaemic cohorts
por: Shovlin, Claire L, et al.
Publicado: (2017)

Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation
por: Magnusson, Jesper, et al.
Publicado: (2018)

A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation
por: Petrov, Andrej A., et al.
Publicado: (2018)

Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018)

Single-Center Long-Term Analysis of Combined Liver-Lung Transplant Outcomes
por: Freischlag, Kyle William, et al.
Publicado: (2018)

Tacrolimus-Induced Hyponatremia in Lung Transplant Recipients: A Case Series
por: Banks, Paul N., et al.
Publicado: (2018)

Neurological Sequelae and Clinical Outcomes After Lung Transplantation
por: Smith, Patrick J., et al.
Publicado: (2018)

Ex Vivo Assessment of Porcine Donation After Circulatory Death Lungs That Undergo Increasing Warm Ischemia Times
por: Charles, Eric J., et al.
Publicado: (2018)

Selective Recruitment of Large Lower Lobe Atelectasis on Donor Back Table in Rejected Donor Lungs
por: Okamoto, Toshihiro, et al.
Publicado: (2019)

Retransplantation Outcomes at a Large Lung Transplantation Program
por: Ren, Dewei, et al.
Publicado: (2018)

Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017)

Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation
por: Müller, Catharina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pj0j7n6ohed0v5bdsndv2gb16b